law360.com
The last week has seen private equity giant Terra Firma sue its former CEO, the
FSCS take on shuttered investment manager Bentley-Leek, and an Italian insurer
lodge a commercial fraud claim against a financial services firm that lost its
U.K. authorization. Here, Law360 looks at those and other new …
over 5 years ago
law360.com
Hundreds of institutional investors have accused Barclays, HSBC and four other
banking giants in London’s High Court of conspiring to rig the foreign exchange
market, seeking billions of dollars in damages for antitrust violations.
almost 6 years ago
law360.com
More than four years after the U.S. Supreme Court’s landmark pay-for-delay
ruling, litigation over the pharmaceutical patent settlements continues to steam
ahead, but Federal Trade Commission Chairman Maureen Ohlhausen indicated the
antitrust enforcer’s crackdown might have at last turned the corner…
almost 7 years ago
law360.com
Litigation funder Vannin Capital has sued for nearly £15 million ($20.4 million)
plus damages and interest from the shareholders who won a £200 million
settlement from Royal Bank of Scotland over its 2008 rights issue.
almost 7 years ago
law360.com
Italy’s antitrust watchdog on Tuesday fined the Big Four auditing firms more
than €23 million ($26.7 million) for rigging bids to provide services to Italy’s
central public procurement operation.
about 7 years ago
law360.com
Tuesday’s decision to let Walgreens forge ahead with its $4.4 billion
acquisition of nearly 2,000 Rite Aid stores highlights the inherent risk of
leaving the Federal Trade Commission with just two top decision makers, but the
split’s rarity underscores how well the agency has continued to function e…
over 7 years ago
law360.com
An Ohio federal judge refused on Thursday to preliminarily block Steris Corp.’s
$1.9 billion acquisition of Synergy Health PLC, concluding that the Federal
Trade Commission didn’t have evidence that U.K.-based Synergy likely would have
launched new competing sterilization technology in the U.S. with…
about 9 years ago
law360.com
Being in the rare position of arguing before the U.S. Supreme Court as an
associate, let alone in a major case concerning federal antitrust scrutiny, is
one clear indication that Jones Day attorney Hashim M. Mooppan — now a partner —
is a Rising Star in the appellate arena.
over 9 years ago
Media DatabaseFind the right journalists
Online NewsroomShape your own narrative
Press Release CreatorCreate and send press releases
Media MonitoringTrack every single online mention
Media Pitching ToolContact recommendations & stats
PR ReportsShowcase the impact of your work
PR CRMManage contacts in easy way
AI PR SoftwareUse AI to save time on your workflow
Social Media ListeningGet a full overview of your brand's presence